Filtered By:
Specialty: Cancer & Oncology
Management: Partnerships
This page shows you your search results in order of date.
Order by Relevance | Date
Total 192 results found since Jan 2013.
In vitro oxygen imaging of acellular and cell-loaded beta cell replacement devices
This article aims to establish the protocols and demonstrate a few examples of in vitro oxygen imaging of BAP devices using EPROI. All pO2 measurements were performed using a recently introduced 720 MHz/25 mT preclinical oxygen imager instrument, JIVA-25™. We began by performing pO2 calibration of the biomaterials used in BAPs at 25 mT magnetic field since no such data exist. We compared the EPROI pO2 measurement with a single-point probe for a few selected materials. We also performed trityl OX071 toxicity studies with fibroblasts, as well as insulin-producing cells (beta TC6, MIN6, and human islet cells). Finally, we p...
Source: Cancer Control - September 20, 2023 Category: Cancer & Oncology Authors: Mrignayani Kotecha Longhai Wang Safa Hameed Navin Viswakarma Minglin Ma Cherie Stabler Corinne A Hoesli Boris Epel Source Type: research
Efficacy of Massage Techniques for Hypertrophic Burn Scars - A Systematic Review of Literature
J Burn Care Res. 2023 Sep 12:irad140. doi: 10.1093/jbcr/irad140. Online ahead of print.ABSTRACTDespite advancements in burn care, evidence estimates that pathological scarring occurs in 32% to 75% of cutaneous burns. Scar massage therapy is an under researched method of management for hypertrophic burn scars which has scope to be a low-cost treatment alternative. The aim of this systematic review was to determine the efficacy of scar massage techniques for common hypertrophic burn scar symptoms such as contraction, pruritus, pain and visibility. The keywords and corresponding MeSH terms were inputed into PubMed, EMBASE, Co...
Source: Cancer Control - September 12, 2023 Category: Cancer & Oncology Authors: Sabrina Poppy Barnes Yangmyung Ma Bijendra Patel Preetha Muthayya Source Type: research
Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model
EClinicalMedicine. 2023 Aug 19;63:102150. doi: 10.1016/j.eclinm.2023.102150. eCollection 2023 Sep.ABSTRACTBACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer, affecting more than 2 million people worldwide yearly and metastasising in 2-5% of patients. However, current clinical staging systems do not provide estimates of absolute metastatic risk, hence missing the opportunity for more personalised treatment advice. We aimed to develop a clinico-pathological model that predicts the probability of metastasis in patients with cSCC.METHODS: Nationwide cohorts from (1) all patients with a first primary c...
Source: Cancer Control - September 4, 2023 Category: Cancer & Oncology Authors: Barbara Rentroia-Pacheco Selin Tokez Edo M Bramer Zoe C Venables Harmen J G van de Werken Domenico Bellomo David van Klaveren Antien L Mooyaart Loes M Hollestein Marlies Wakkee Source Type: research
Leveraging an implementation science partnership network to understand how Federally Qualified Health Centers operationalize and address health equity
We examined how health equity was operationalized and addressed at Federally Qualified Health Centers (FQHCs). We conducted semi-structured interviews with leadership (n = 19) and staff (n = 12) at 10 FQHCs in an implementation science partnership network for cancer control equity to understand how they operationalized and addressed health equity. We performed rapid qualitative analysis and shared findings with a larger group of 13 community health centers (including the 10 FQHCs) at an Implementation Learning Community (ILC) to identify action areas for research and practice, followed by a second phase of synthesizing qua...
Source: Cancer Control - August 5, 2023 Category: Cancer & Oncology Authors: Kelly A Aschbrenner Jennifer L Cruz Gina R Kruse Huy Nguyen Cristina Huebner Torres Maria Celli Carrie Sarcione Deepinder Singh Karen M Emmons Source Type: research
How Patients Cope Throughout the Course of an Incurable Cancer
Clin Colorectal Cancer. 2023 Jul 10:S1533-0028(23)00062-2. doi: 10.1016/j.clcc.2023.07.003. Online ahead of print.ABSTRACTPatients cope in different ways when living with an incurable cancer. These varied coping styles impact how oncology providers communicate with patients. If providers do not tailor communication with a general understanding of how a patient is coping, this risks miscommunication with the patient, inaccurate disease understanding, and suboptimal care. This review explores the spectrum of coping patterns that influence a patient's behaviors and communication with their oncology team throughout a cancer co...
Source: Clinical Colorectal Cancer - July 28, 2023 Category: Cancer & Oncology Authors: Ariana Bauer Melissa Teply Source Type: research
Research-practice partnership: supporting rural cancer survivors in Montana
The objective of this Research-Practice Partnership was to disseminate and implement strategies to assist Community Health Centers in improving the care of rural cancer survivors in Montana. Funded by the National Cancer Institute's Community Outreach and Engagement mechanism, this project utilized the MAP-IT (Mobilize, Assess, Plan, Implement, Track) program planning framework from Healthy People 2020. Partners included Montana's Department of Public Health and Human Services' Cancer Control Program, Montana Primary Care Association, One Health Community Health Center, and Huntsman Cancer Institute at the University of Ut...
Source: Cancer Control - July 25, 2023 Category: Cancer & Oncology Authors: Janna R Gordon Melissa Yack Kara Kikuchi Leticia Stevens Leah Merchant Courtney Buys Laura Gottschalk Melanie Frame Jessica Mussetter Stephanie Younkin Heather Zimmerman Anne C Kirchhoff David W Wetter Source Type: research
Engaging the community served: a U.S. Cancer Center's Facebook live cancer awareness campaign for Spanish-speaking Latinos during COVID-19
Cancer Causes Control. 2023 Jul 25. doi: 10.1007/s10552-023-01755-2. Online ahead of print.ABSTRACTCancer is the leading cause of mortality in U.S. Latino adults, a group with limited access to screening, higher rates of advanced disease, and prone to online misinformation. Our project created a Facebook Live social media video campaign on general cancer prevention, screening, risk, information, and resources, targeting Spanish-monolingual Latinos during the COVID-19 pandemic. Content was delivered in Spanish by fluent, ethnically concordant topic experts and cancer center staff. Four prerecorded and three livestream inter...
Source: Cancer Control - July 25, 2023 Category: Cancer & Oncology Authors: Javier Mora Raul Romo Sandra Dempsey Betzaida Silva Debra Nevels Gustavo W Leone Melinda Stolley Source Type: research
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
Curr Oncol. 2023 Jun 13;30(6):5738-5768. doi: 10.3390/curroncol30060431.ABSTRACTThis guideline provides evidence-based guidance on the risk-based management of cervical dysplasia in the colposcopy setting in the context of primary HPV-based screening and HPV testing in colposcopy. Colposcopy management of special populations is also discussed. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC) and the Canadian Partnership Against Cancer (CPAC). The literature informing these guidelines was obtained through a systema...
Source: Current Oncology - June 27, 2023 Category: Cancer & Oncology Authors: Karla Willows Amanda Selk Marie-H élène Auclair Brent Jim Naana Jumah Jill Nation Lily Proctor Melissa Iazzi James Bentley Source Type: research
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
Curr Oncol. 2023 Jun 9;30(6):5652-5679. doi: 10.3390/curroncol30060425.ABSTRACTThe purpose of this paper is to provide evidence-based guidance on the management of a positive human papilloma virus (HPV) test and to provide guidance around screening and HPV testing for specific patient populations. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC), and the Canadian Partnership Against Cancer. The literature informing these guidelines was obtained through a systematic review of relevant literature by a multi-step sea...
Source: Current Oncology - June 27, 2023 Category: Cancer & Oncology Authors: Tiffany Zigras Marie-H élène Mayrand Celine Bouchard Shannon Salvador Lua Eiriksson Chelsea Almadin Sarah Kean Erin Dean Unjali Malhotra Nicole Todd Daniel Fontaine James Bentley Source Type: research
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
Curr Oncol. 2023 Jun 13;30(6):5738-5768. doi: 10.3390/curroncol30060431.ABSTRACTThis guideline provides evidence-based guidance on the risk-based management of cervical dysplasia in the colposcopy setting in the context of primary HPV-based screening and HPV testing in colposcopy. Colposcopy management of special populations is also discussed. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC) and the Canadian Partnership Against Cancer (CPAC). The literature informing these guidelines was obtained through a systema...
Source: Current Oncology - June 27, 2023 Category: Cancer & Oncology Authors: Karla Willows Amanda Selk Marie-H élène Auclair Brent Jim Naana Jumah Jill Nation Lily Proctor Melissa Iazzi James Bentley Source Type: research
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
Curr Oncol. 2023 Jun 9;30(6):5652-5679. doi: 10.3390/curroncol30060425.ABSTRACTThe purpose of this paper is to provide evidence-based guidance on the management of a positive human papilloma virus (HPV) test and to provide guidance around screening and HPV testing for specific patient populations. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC), and the Canadian Partnership Against Cancer. The literature informing these guidelines was obtained through a systematic review of relevant literature by a multi-step sea...
Source: Current Oncology - June 27, 2023 Category: Cancer & Oncology Authors: Tiffany Zigras Marie-H élène Mayrand Celine Bouchard Shannon Salvador Lua Eiriksson Chelsea Almadin Sarah Kean Erin Dean Unjali Malhotra Nicole Todd Daniel Fontaine James Bentley Source Type: research
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
Curr Oncol. 2023 Jun 13;30(6):5738-5768. doi: 10.3390/curroncol30060431.ABSTRACTThis guideline provides evidence-based guidance on the risk-based management of cervical dysplasia in the colposcopy setting in the context of primary HPV-based screening and HPV testing in colposcopy. Colposcopy management of special populations is also discussed. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC) and the Canadian Partnership Against Cancer (CPAC). The literature informing these guidelines was obtained through a systema...
Source: Current Oncology - June 27, 2023 Category: Cancer & Oncology Authors: Karla Willows Amanda Selk Marie-H élène Auclair Brent Jim Naana Jumah Jill Nation Lily Proctor Melissa Iazzi James Bentley Source Type: research
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
Curr Oncol. 2023 Jun 9;30(6):5652-5679. doi: 10.3390/curroncol30060425.ABSTRACTThe purpose of this paper is to provide evidence-based guidance on the management of a positive human papilloma virus (HPV) test and to provide guidance around screening and HPV testing for specific patient populations. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC), and the Canadian Partnership Against Cancer. The literature informing these guidelines was obtained through a systematic review of relevant literature by a multi-step sea...
Source: Current Oncology - June 27, 2023 Category: Cancer & Oncology Authors: Tiffany Zigras Marie-H élène Mayrand Celine Bouchard Shannon Salvador Lua Eiriksson Chelsea Almadin Sarah Kean Erin Dean Unjali Malhotra Nicole Todd Daniel Fontaine James Bentley Source Type: research
